We subsequently formulated a more distinct probe, [18F]CFA, which was Employed in the current study To guage dCK activity in tumors when addressed with a small molecule dCK inhibitor. This probe is additionally remaining studied in a very medical demo at our institution To judge modifications in dCK action next most cancers immunotherapy 18. PET pr